Literature DB >> 20847971

Thirty-day in-hospital revascularization and mortality rates after acute myocardial infarction in seven Canadian provinces.

Helen Johansen1, Susan E Brien, Philippe Finès, Julie Bernier, Karin Humphries, Therese A Stukel, William A Ghali.   

Abstract

BACKGROUND: Recent clinical trials have demonstrated benefit with early revascularization following acute myocardial infarction (AMI). Trends in and the association between early revascularization after (ie, 30 days or fewer) AMI and early death were determined. METHODS AND
RESULTS: The Statistics Canada Health Person-Oriented Information Database, consisting of hospital discharge records for seven provinces from the Canadian Institute for Health Information Hospital Morbidity Database, was used. If there was no AMI in the preceding year, the first AMI visit within a fiscal year for a patient 20 years of age or older was included. Times to death in hospital and to revascularization procedures were counted from the admission date of the first AMI visit. Mixed model regression analyses with random slopes were used to assess the relationship between early revascularization and mortality. The overall rate of revascularization within 30 days of AMI increased significantly from 12.5% in 1995 to 37.4% in 2003, while the 30-day mortality rate decreased significantly from 13.5% to 10.6%. There was a linearly decreasing relationship - higher regional use of revascularization was associated with lower mortality in both men and women.
CONCLUSIONS: These population-based utilization and outcome findings are consistent with clinical trial evidence of improved 30-day in-hospital mortality with increased early revascularization after AMI.

Entities:  

Mesh:

Year:  2010        PMID: 20847971      PMCID: PMC2950718          DOI: 10.1016/s0828-282x(10)70415-3

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  25 in total

Review 1.  Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.

Authors:  James K Liao
Journal:  Am J Cardiol       Date:  2005-09-05       Impact factor: 2.778

2.  Drug-eluting stents: a study of international practice.

Authors:  David Austin; Keith G Oldroyd; David R Holmes; Charanjit S Rihal; P Diane Galbraith; William A Ghali; Victor Legrand; Yves Taeymans; Alex McConnachie; Jill P Pell
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

3.  5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study.

Authors:  Bo Lagerqvist; Steen Husted; Fredrik Kontny; Elisabeth Ståhle; Eva Swahn; Lars Wallentin
Journal:  Lancet       Date:  2006-09-16       Impact factor: 79.321

Review 4.  Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era.

Authors:  M R Hoenig; J A Doust; C N Aroney; I A Scott
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 5.  Early intervention and prevention of myocardial infarction.

Authors:  Prem S Pais
Journal:  J Hypertens Suppl       Date:  2006-04

6.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

7.  Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).

Authors:  David A Cox; Gregg W Stone; Cindy L Grines; Thomas Stuckey; Peter J Zimetbaum; James E Tcheng; Mark Turco; Eulogio Garcia; Giulio Guagliumi; Robert S Iwaoka; Roxana Mehran; William W O'Neill; Alexandra J Lansky; John J Griffin
Journal:  Am J Cardiol       Date:  2006-06-09       Impact factor: 2.778

8.  Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.

Authors:  Carlo Di Mario; Dariusz Dudek; Federico Piscione; Waldemar Mielecki; Stefano Savonitto; Ernesto Murena; Konstantinos Dimopoulos; Antonio Manari; Achille Gaspardone; Andrzej Ochala; Krzysztof Zmudka; Leonardo Bolognese; Philippe Gabriel Steg; Marcus Flather
Journal:  Lancet       Date:  2008-02-16       Impact factor: 79.321

9.  Potential shift from coronary bypass surgery to percutaneous coronary intervention for multivessel disease and its economic impact in the drug-eluting stent era.

Authors:  Frédéric Poulin; Stéphane Rinfret; François Gobeil
Journal:  Can J Cardiol       Date:  2007-12       Impact factor: 5.223

10.  Variations by health region in treatment and survival after heart attack.

Authors:  Helen Johansen; Julie Bernier; Philippe Finès; Susan Brien; William Ghali; Michael Wolfson
Journal:  Health Rep       Date:  2009-06       Impact factor: 4.796

View more
  2 in total

1.  Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine.

Authors:  Raffaele Altara; Marco Manca; Ramzi Sabra; Assaad A Eid; George W Booz; Fouad A Zouein
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

2.  Area Median Income and Metropolitan Versus Nonmetropolitan Location of Care for Acute Coronary Syndromes: A Complex Interaction of Social Determinants.

Authors:  Gabriel E Fabreau; Alexander A Leung; Danielle A Southern; Matthew T James; Merrill L Knudtson; William A Ghali; John Z Ayanian
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.